49 related articles for article (PubMed ID: 10827151)
1. Expression of an intestine-specific transcription factor (CDX1) in intestinal metaplasia and in subsequently developed intestinal type of cholangiocarcinoma in rat liver.
Ren P; Silberg DG; Sirica AE
Am J Pathol; 2000 Feb; 156(2):621-7. PubMed ID: 10666391
[TBL] [Abstract][Full Text] [Related]
2. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.
Affo S; Nair A; Brundu F; Ravichandra A; Bhattacharjee S; Matsuda M; Chin L; Filliol A; Wen W; Song X; Decker A; Worley J; Caviglia JM; Yu L; Yin D; Saito Y; Savage T; Wells RG; Mack M; Zender L; Arpaia N; Remotti HE; Rabadan R; Sims P; Leblond AL; Weber A; Riener MO; Stockwell BR; Gaublomme J; Llovet JM; Kalluri R; Michalopoulos GK; Seki E; Sia D; Chen X; Califano A; Schwabe RF
Cancer Cell; 2021 Jun; 39(6):866-882.e11. PubMed ID: 33930309
[TBL] [Abstract][Full Text] [Related]
3. A Novel Mouse Model of Intrahepatic Cholangiocarcinoma Induced by Azoxymethane.
Shirakami Y; Kato J; Ohnishi M; Taguchi D; Maeda T; Ideta T; Kubota M; Sakai H; Tomita H; Tanaka T; Shimizu M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834032
[TBL] [Abstract][Full Text] [Related]
4. Risks for public health related to the presence of furan and methylfurans in food.
; Knutsen HK; Alexander J; Barregård L; Bignami M; Brüschweiler B; Ceccatelli S; Cottrill B; Dinovi M; Edler L; Grasl-Kraupp B; Hogstrand C; Hoogenboom LR; Nebbia CS; Oswald IP; Petersen A; Rose M; Roudot AC; Schwerdtle T; Vleminckx C; Vollmer G; Chipman K; De Meulenaer B; Dinovi M; Mennes W; Schlatter J; Schrenk D; Baert K; Dujardin B; Wallace H
EFSA J; 2017 Oct; 15(10):e05005. PubMed ID: 32625300
[TBL] [Abstract][Full Text] [Related]
5. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.
Affo S; Yu LX; Schwabe RF
Annu Rev Pathol; 2017 Jan; 12():153-186. PubMed ID: 27959632
[TBL] [Abstract][Full Text] [Related]
6. The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?
Ilyas SI; Borad MJ
J Gastrointest Oncol; 2016 Oct; 7(5):789-796. PubMed ID: 27747092
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of cholangiocarcinoma.
Rizvi S; Gores GJ
Dig Dis; 2014; 32(5):564-9. PubMed ID: 25034289
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Ilyas SI; Gores GJ
Gastroenterology; 2013 Dec; 145(6):1215-29. PubMed ID: 24140396
[TBL] [Abstract][Full Text] [Related]
9. Novel organotypic culture model of cholangiocarcinoma progression.
Campbell DJ; Dumur CI; Lamour NF; Dewitt JL; Sirica AE
Hepatol Res; 2012 Nov; 42(11):1119-30. PubMed ID: 22568523
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of cholangiocarcinoma.
Fava G
World J Gastrointest Pathophysiol; 2010 Apr; 1(1):12-22. PubMed ID: 21607138
[TBL] [Abstract][Full Text] [Related]
11. Age dependence of oval cell responses and bile duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, ethionine-supplemented diet.
Guest I; Ilic Z; Sell S
Hepatology; 2010 Nov; 52(5):1750-7. PubMed ID: 20842700
[TBL] [Abstract][Full Text] [Related]
12. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
Menakongka A; Suthiphongchai T
World J Gastroenterol; 2010 Feb; 16(6):713-22. PubMed ID: 20135719
[TBL] [Abstract][Full Text] [Related]
13. Genetic and molecular abnormalities in cholangiocarcinogenesis.
Hassid VJ; Orlando FA; Awad ZT; Tan D; Khoury T; Ahmed BH; Alrawi SJ
Anticancer Res; 2009 Apr; 29(4):1151-6. PubMed ID: 19414358
[TBL] [Abstract][Full Text] [Related]
14. Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.
Sirica AE
World J Gastroenterol; 2008 Dec; 14(46):7033-58. PubMed ID: 19084911
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.
Blechacz B; Gores GJ
Hepatology; 2008 Jul; 48(1):308-21. PubMed ID: 18536057
[No Abstract] [Full Text] [Related]
16. Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation.
Xue F; Takahara T; Yata Y; Minemura M; Morioka CY; Takahara S; Yamato E; Dono K; Watanabe A
Gut; 2002 Apr; 50(4):558-62. PubMed ID: 11889079
[TBL] [Abstract][Full Text] [Related]
17. Liver damage using suicide genes. A model for oval cell activation.
Bustos M; Sangro B; Alzuguren P; Gil AG; Ruiz J; Beraza N; Qian C; Garcia-Pardo A; Prieto J
Am J Pathol; 2000 Aug; 157(2):549-59. PubMed ID: 10934157
[TBL] [Abstract][Full Text] [Related]
18. Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver.
Lai GH; Radaeva S; Nakamura T; Sirica AE
Hepatology; 2000 Jun; 31(6):1257-65. PubMed ID: 10827151
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma.
Radaeva S; Ferreira-Gonzalez A; Sirica AE
Hepatology; 1999 May; 29(5):1453-62. PubMed ID: 10216129
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
